SENSEONICSHOLDINGS,INC. (NYSEMKT:SENS) Files An 8-K Submission of Matters to a Vote of Security Holders

SENSEONICSHOLDINGS,INC. (NYSEMKT:SENS) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07Submission of Matters to a Vote of Security Holders.

On May 24, 2017, Senseonics Holdings, Inc. (the Company) held its
2017 annual meeting of stockholders (the Annual Meeting). The
stockholders considered two proposals, each of which is described
in more detail in the Companys definitive proxy statement filed
with the Securities and Exchange Commission on April 17, 2017.Of
the 94,101,378 shares outstanding as of the record date,
76,415,433 shares, or 81%, were present or represented by proxy
at the Annual Meeting.Set forth below are the results of the
matters submitted for a vote of stockholders at the Annual
Meeting.

Proposal No. 1:Election of two nominees to serve as directors
until the 2020 annual meeting of stockholders and until their
respective successors are elected and qualified. The votes were
cast as follows:

Broker Non-Votes: __13,025,453

All nominees were elected.

Proposal No. 2:Ratification of the appointment of Ernst Young LLP
as independent registered public accounting firm for the fiscal
year ending December 31, 2017. The votes were cast as follows:

About SENSEONICS HOLDINGS, INC. (NYSEMKT:SENS)
Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company’s Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user’s mobile device, such as a smartphone, Apple Watch or tablet. SENSEONICS HOLDINGS, INC. (NYSEMKT:SENS) Recent Trading Information
SENSEONICS HOLDINGS, INC. (NYSEMKT:SENS) closed its last trading session up +0.06 at 1.41 with 315,055 shares trading hands.